Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)

Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)

US Patent 12110324 · Granted Oct 8, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interferon beta antibodies and uses thereof2025
Modulators of parathyroid hormone receptor (PTHR1)2025
Antibodies specific for GUCY2c and uses thereof2025
Antigen binding molecules targeting SARS-CoV-22024
Antigen binding molecules targeting SARS-CoV-22024
Interferon beta antibodies and uses thereof2024
Simulating the metabolic pathway dynamics of an organism2023
Methods of administering a composition comprising a Tn3 scaffold and a CD40L-spe2023
Antibodies specific for GUCY2c and uses thereof2022
Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subuni2021
Interferon beta antibodies and uses thereof2020
DDR2 mutations in squamous cell lung cancer2019